Establishment Labs Holdings Stock Today
| ESTA Stock | USD 46.07 0.50 1.10% |
Performance2 of 100
| Odds Of DistressLess than 26
|
Establishment Labs is trading at 46.07 as of the 28th of November 2024, a 1.10 percent increase since the beginning of the trading day. The stock's open price was 45.57. Establishment Labs has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Establishment Labs Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 19th of July 2018 | Category Healthcare | Classification Health Care |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica. The company has 28.76 M outstanding shares of which 5.12 M shares are currently shorted by private and institutional investors with about 10.82 trading days to cover. More on Establishment Labs Holdings
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Establishment Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO, Director | Juan Quiros | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Jakarta Stock Exchange, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsEstablishment Labs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Establishment Labs' financial leverage. It provides some insight into what part of Establishment Labs' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Establishment Labs Holdings (ESTA) is traded on NASDAQ Exchange in USA. It is located in Building B15 and 25, Alajuela, Costa Rica and employs 908 people. Establishment Labs is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.31 B. Establishment Labs conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 28.76 M outstanding shares of which 5.12 M shares are currently shorted by private and institutional investors with about 10.82 trading days to cover.
Establishment Labs Holdings currently holds about 65.35 M in cash with (88.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68.
Check Establishment Labs Probability Of Bankruptcy
Ownership AllocationEstablishment Labs holds a total of 28.76 Million outstanding shares. The majority of Establishment Labs Holdings outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Establishment Labs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Establishment Labs. Please pay attention to any change in the institutional holdings of Establishment Labs Holdings as this could imply that something significant has changed or is about to change at the company. Also note that almost two million eight hundred fourty-four thousand seven hundred twenty invesors are currently shorting Establishment Labs expressing very little confidence in its future performance.
Check Establishment Ownership Details
Establishment Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Polar Capital Holdings Plc | 2024-06-30 | 546.5 K | |
| Bamco Inc | 2024-09-30 | 489.4 K | |
| Balyasny Asset Management Llc | 2024-09-30 | 480.2 K | |
| Sofinnova Ventures | 2024-06-30 | 429.2 K | |
| First Turn Management Llc | 2024-09-30 | 357 K | |
| Mudita Advisors Llp | 2024-09-30 | 354.8 K | |
| Divisadero Street Capital Management, Lp | 2024-09-30 | 341.1 K | |
| Boothbay Fund Management, Llc | 2024-09-30 | 311.1 K | |
| Affinity Asset Advisors, Llc | 2024-09-30 | 290.4 K | |
| Jw Asset Management, Llc | 2024-09-30 | 3.2 M | |
| Rtw Investments, Llc | 2024-06-30 | 2.7 M |
Establishment Labs Historical Income Statement
Establishment Stock Against Markets
Establishment Labs Corporate Management
| Heather Brennan | Head Operations | Profile | |
| Roberto Mezerville | Chief Officer | Profile | |
| Paul Rodio | Chief Officer | Profile | |
| Jeff Ehrhard | Senior America | Profile | |
| Ivan Bilic | Senior OUS | Profile | |
| Ross Mansbach | General Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Revenue Per Share 5.58 | Quarterly Revenue Growth 0.045 | Return On Assets (0.12) | Return On Equity (2.23) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.